Sheets Smith Wealth Management Purchases New Position in ProPhase Labs, Inc. (NASDAQ:PRPH)

Sheets Smith Wealth Management acquired a new position in ProPhase Labs, Inc. (NASDAQ:PRPH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 208,300 shares of the company’s stock, valued at approximately $158,000. Sheets Smith Wealth Management owned 0.87% of ProPhase Labs at the end of the most recent quarter.

Separately, HighTower Advisors LLC boosted its holdings in shares of ProPhase Labs by 18.3% in the third quarter. HighTower Advisors LLC now owns 179,045 shares of the company’s stock worth $434,000 after acquiring an additional 27,673 shares during the period. 9.45% of the stock is owned by institutional investors.

ProPhase Labs Stock Performance

NASDAQ:PRPH opened at $0.51 on Thursday. The business’s fifty day moving average is $0.69 and its 200 day moving average is $1.89. The firm has a market cap of $12.20 million, a price-to-earnings ratio of -0.41 and a beta of -0.30. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.33 and a current ratio of 1.47. ProPhase Labs, Inc. has a 52-week low of $0.46 and a 52-week high of $7.48.

ProPhase Labs Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.